Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms including inattention, hyperactivity, impulsivity, and emotional dysregulation, which are excessive, pervasive, and impairing in multiple contexts as well as being age-inappropriate. Though it is often diagnosed in children, ADHD is nearly as common in adults.
Health Outcomes
- Altered Catecholamine Level
- Altered Monoamine Signaling
- Demonstrated Long-term Safety
- Improved ADHD-Related Symptoms
- Improved ASD Symptoms
- Improved Analytical Accuracy
- Improved Attention Score
- Improved Attention Span
- Improved Behavior
- Improved Behavioral Symptoms in Younger Children
- Improved Catecholamine Status
- Improved Cognition
- Improved Cognitive Behavior
- Improved Cognitive Development
- Improved Cognitive Flexibility
- Improved Cognitive Performance
- Improved Decision-Making Accuracy
- Improved Developmental Milestone
- Improved Distractor Interference
- Improved Focus
- Improved Full Scale Intelligence Quotient
- Improved Global Assessment
- Improved Learning
- Improved Mathematical Processing
- Improved Neurobehavioral Function
- Improved Neurofibromatosis
- Improved Neurological Health
- Improved Neurotransmitter Metabolism
- Improved Neurotransmitter Profile
- Improved Opposition and Defiance Behaviors
- Improved Performance Developmental Score
- Improved Performance Mastery
- Improved Problem-Solving Skills
- Improved Processing Speed
- Improved Psychomotor Development
- Improved Reaction Time
- Improved SNAP-IV Score for Younger Children
- Improved SNAP-IV Scores
- Improved SNAP-IV Total Score
- Improved SNAP-IV Total Score for Children Aged 7-12
- Improved Set-Shifting Reaction Time
- Improved Simon Task Accuracy
- Improved Simulated Game Total Completion Time
- Improved Social Behavior
- Improved Socialization
- Improved Strategic Efficiency
- Improved Therapeutic Consistency
- Improved Work Performance
- Improved Working Memory
- Increased Distractibility
- Increased Exploratory Behavior
- Increased Irritability
- Increased Locomotor Activity During Active Phase
- Increased Systemic GABA Levels
- Maintained Normal Behavior
- Modified Resting-State Brain Connectivity
- No CYP1A2 or CYP3A4 Interaction
- No Significant Difference Compared to Placebo
- No Significant Improvement in ADHD Symptoms
- Reduced ADHD Symptom
- Reduced Anger
- Reduced Behavioral Difficulty
- Reduced Commission Error
- Reduced Day School Absenteeism
- Reduced Hyperactivity
- Reduced Hyperactivity Symptoms
- Reduced Inattention Symptoms
- Reduced Interference Score on Simon Task
- Reduced Irritability
- Reduced Mental Fatigue
- Reduced Missed Response
- Reduced Oppositional/Defiant Behaviors
- Reduced Prefrontal Cortex Oxygenated Hemoglobin
- Reduced Response Time on Flanker Task
- Reduced Simple Reaction Time
- Reduced Vigilance Behavior
- Stabilized Dopamine Pathway Function
- Unchanged Risk of Sepsis